ホーム › 肝臓がん（肝細胞がん） › フロリダ州
フロリダ州における肝臓がん（肝細胞がん）の臨床試験
フロリダ州内の拠点で、肝臓がん（肝細胞がん）に関する27件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06265285A Phase 1 Study of the Safety and Tolerability of CTX-10726
- Mayo Clinic Florida, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
- Research Facility, Jacksonville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06726161Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
- Moffitt Cancer Center at Speros, Land O' Lakes
- Moffitt Cancer Center at SouthShore, Ruskin
- Moffitt Cancer Center - International Plaza, Tampa
- 他4件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07227012Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- AdventHealth Celebration, Celebration
- Lee Health Cancer Institute, Fort Myers
被験者募集中観察研究
22歳以上 · 全性別 · 2026/09/11更新 · NCT06486454Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Jacksonville
- Research Site, Orlando
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06921785Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Jacksonville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Miami Hospital and Clinics, Miami
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
- University of Florida, Gainesville
被験者募集中第2相
18歳〜99歳 · 全性別 · 2026/07/14更新 · NCT05669339Multi-analyte Blood Test Clinical Trial
- UF Hepatology Research at CTRB, Gainesville
- Guardian Angel Research Center, Tampa
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/10更新 · NCT05199259Targeted Navigation in Hepatocellular Carcinoma (HCC)
- University of Miami, Miami
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/02更新 · NCT06260943PSMA PET for the Staging and Management of Hepatocellular Carcinoma
- Miami VA Healthcare System, Miami, FL, Miami
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/26更新 · NCT07019844A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/17更新 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Miami VA Healthcare System, Miami, FL, Miami
被験者募集中
18歳〜75歳 · 全性別 · 2026/06/17更新 · NCT05486572Intravital Microscopy in Human Solid Tumors
- Mayo Clinic Florida, Jacksonville
被験者募集中
18歳以上 · 全性別 · 2026/06/02更新 · NCT03823144DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA08-0, Florida City
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/27更新 · NCT05440708Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics), Miami
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/02更新 · NCT05733598Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/01更新 · NCT06553885Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
- Cancer Specialists of North Florida, Jacksonville
- D&H National Research Centers, LLC, Margate
- Mid Florida Hematology and oncology Center, Orange City
- 他2件
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/03/16更新 · NCT07176650Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Florida, Jacksonville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 118, Celebration
- Research Site 127, Margate
- Research Site 137, Orlando
- 他2件
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/25更新 · NCT05824975ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。